Pharmaceuticals (106) | Exchange Agreements (106)

Browse by Company

Acacia Diversified Holdings, Inc. (1 contract)
Accelerated Pharma, Inc. (4)
Amag Pharmaceuticals (1)
Artemis Therapeutics, Inc. (2)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (1)
ATAI Life Sciences B.V. (1)
AVADEL PHARMACEUTICALS PLC (2)
AYTU BIOSCIENCE, INC (2)
Bespoke Extracts, Inc. (3)
Biofrontera Inc. (1)
BioPharmX Corp (1)
Boston Therapeutics, Inc. (2)
Canbiola, Inc. (2)
Catalent Inc (1)
Celexus, Inc (2)
CorMedix Inc. (1)
CUMBERLAND PHARMACEUTICALS INC (4)
Egalet Corp (1)
Endexx Corp (3)
EPHS HOLDINGS, INC. (1)
Evofem Biosciences, Inc. (6)
Exactus, Inc. (4)
FRONTIER OILFIELD SERVICES INC (2)
GridIron BioNutrients, Inc. (1)
INNOVATE BIOPHARMACEUTICALS, INC. (1)
Jaguar Health, Inc. (6)
Kaya Holdings, Inc. (1)
KEMPHARM, INC (6)
Lannett Company, Inc. (2)
Longboard Pharmaceuticals, Inc. (1)
Mallinckrodt (2)
Marijuana Co of America, Inc. (2)
MICROCHANNEL TECHNOLOGIES CORP (2)
Milestone Pharmaceuticals Inc. (1)
MYnd Analytics, Inc. (1)
Notis Global, Inc. (1)
PaxMedica, Inc. (1)
QUANTA INC (1)
Rain Therapeutics Inc. (2)
Rani Therapeutics Holdings, Inc. (2)
RELMADA THERAPEUTICS, INC. (1)
RespireRx Pharmaceuticals Inc. (10)
Royalty Pharma plc (3)
Scopus BioPharma Inc. (2)
SIGA TECHNOLOGIES INC (1)
Target Group Inc. (1)
Terra Tech Corp. (1)
TETRAPHASE PHARMACEUTICALS INC (2)
Textmunication Holdings, Inc. (1)
WEED, INC. (1)
XERIS PHARMACEUTICALS INC (1)

Recent Contracts

Exchange Agreement, dated as of March 22, 2023, by and among the Company and certain investors party thereto (Milestone Pharmaceuticals Inc., Filed With SEC on March 27, 2023)
Form of Exchange Agreement (Assertio Holdings, Inc., Filed With SEC on February 23, 2023)
Form of Exchange Agreement (Biofrontera Inc., Filed With SEC on October 31, 2022)
Form of Exchange Agreement (Scopus BioPharma Inc., Filed With SEC on October 20, 2022)
Exchange Agreement between Relmada Therapeutics, Inc., and Venrock Healthcare Capital Partners EG, L.P., Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings... (RELMADA THERAPEUTICS, INC., Filed With SEC on September 22, 2022)
Form of Adjuvant Exchange Agreement (Evofem Biosciences, Inc., Filed With SEC on September 16, 2022)
Form of Investor Exchange Agreement (Evofem Biosciences, Inc., Filed With SEC on September 16, 2022)
Form of Contribution and Exchange Agreement among the registrant, CBD Unlimited, Inc., Todd Allen Davis, and Rayne Forecast Inc., effective August 31 (Endexx Corp, Filed With SEC on September 7, 2022)
Form of Series Seed Exchange Agreement (PaxMedica, Inc., Filed With SEC on August 8, 2022)
Share Exchange Agreement with Hempirical Genetics, LLC dated May 2, 2022 (WEED, INC., Filed With SEC on August 4, 2022)
First Amendment to the Share Exchange Agreement by and between Artemis Therapeutics, Inc., Manuka Ltd., an Israeli company and the shareholders of Manuka Ltd., dated June 30, 2022 (Artemis Therapeutics, Inc., Filed With SEC on July 5, 2022)
Arena Exchange Agreement (Canbiola, Inc., Filed With SEC on June 30, 2022)
Share Exchange Agreement by and between Artemis Therapeutics, Inc., Manuka Ltd., an Israeli company and the shareholders of Manuka Ltd., dated March 6, 2022 (Artemis Therapeutics, Inc., Filed With SEC on May 23, 2022)
Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between James L. Herman and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 13, 2022)
Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between John M. Hamm and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 13, 2022)
Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between Leo B. Pavliv and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 13, 2022)
Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 13, 2022)
Form of Amendment and Exchange Agreement For Preferred Stock (Evofem Biosciences, Inc., Filed With SEC on May 5, 2022)
Form of Amendment and Exchange Agreement For Equity Line Shares (Evofem Biosciences, Inc., Filed With SEC on May 5, 2022)
Form of Amendment and Exchange Agreement For Existing Notes (Evofem Biosciences, Inc., Filed With SEC on May 5, 2022)
Class B Unit Exchange Agreement, effective as of August 3, 2021 (Rani Therapeutics Holdings, Inc., Filed With SEC on March 31, 2022)
Exchange Agreement between Todd Davis and the Registrant, effective as of September 30, 2021 (Endexx Corp, Filed With SEC on March 31, 2022)
Exchange Agreement between Rayne Forecast, Inc., and the Registrant, effective as of September 30, 2021 (Endexx Corp, Filed With SEC on March 31, 2022)
Form of Exchange Agreement (Evofem Biosciences, Inc., Filed With SEC on March 24, 2022)
Form of Exchange Agreement between the Issuer, the Company and certain holders of the Existing Notes (AVADEL PHARMACEUTICALS PLC, Filed With SEC on March 16, 2022)
Form of Exchange Agreement between Avadel Finance Cayman Limited, Avadel Pharmaceuticals plc and certain holders of its February 2023 Notes (AVADEL PHARMACEUTICALS PLC, Filed With SEC on March 16, 2022)
Form of Exchange Agreement (Exactus, Inc., Filed With SEC on March 4, 2022)
Exhibit 2.1Agreement and Plan of Share Exchange dated December 28, 2021 by and between Triccar Inc., Correlate Inc. and the Correlate shareholders (FRONTIER OILFIELD SERVICES INC, Filed With SEC on January 3, 2022)
Exhibit 2.2Agreement and Plan of Share Exchange dated December 28, 2021 by and between Triccar Inc., Loyal Enterprises LLC and the Loyal Members (FRONTIER OILFIELD SERVICES INC, Filed With SEC on January 3, 2022)
Exchange Agreement dated December 27, 2021 (Kaya Holdings, Inc., Filed With SEC on December 29, 2021)
Note Exchange Agreement (Exactus, Inc., Filed With SEC on August 23, 2021)
Stock Exchange Agreement, dated June 25, 2021 (Scopus BioPharma Inc., Filed With SEC on August 13, 2021)
Note Termination and Exchange Agreement between Unrivaled Brands, Inc. and Arthur Chan, dated July 27, 2021 (Terra Tech Corp., Filed With SEC on August 2, 2021)
Form of Class B Unit Exchange Agreement, to be effective upon the closing of this offering (Rani Therapeutics Holdings, Inc., Filed With SEC on July 16, 2021)
Form of Exchange Agreement, dated June 25, 2021, with existing holders of convertible promissory notes (Boston Therapeutics, Inc., Filed With SEC on June 29, 2021)
Exchange Agreement (MICROCHANNEL TECHNOLOGIES CORP, Filed With SEC on June 15, 2021)
Service Agreement, dated June 5, 2019, between the Registrant and Florian Brand, as amended by agreement dated June 10, 2021 (ATAI Life Sciences B.V., Filed With SEC on June 11, 2021)
Exchange Agreement, dated April 17, 2021, by and among the Registrant and the stockholders listed therein (Rain Therapeutics Inc., Filed With SEC on April 19, 2021)
Amended and Restated Exchange Agreement dated April 8, 2021, among Lannett Company, Inc. and the participating lenders party thereto (Lannett Company, Inc., Filed With SEC on April 12, 2021)
Exchange Agreement dated as of April 9, 2021 by and between Gridiron BioNutrients, Inc. and Calvary Fund Management, LLP (GridIron BioNutrients, Inc., Filed With SEC on April 12, 2021)